Greyson International, Inc. Announces a Tier Upgrade of Its Common Stock by OTC Markets and Shareholder Update

COCONUT CREEK, Fla.--()--Greyson International, Inc. (Pink Sheets:GYSN), developer of an innovative topical delivery technology, today announced that its common stock listed on OTC Markets has been upgraded to OTC Pink Current Information. The designation is for companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to OTC Markets Group Guidelines for Providing Adequate Current Information.

“Our goal is to transition Greyson International to a fully reporting company”

“Our goal is to transition Greyson International to a fully reporting company,” said Harvey Tauman, CEO of Greyson International Inc. “We are pleased that we have reached the highest tier in the OTC Pink Markets by completing and filing three years of audited financials in addition to having all of our quarterly filings released on time. Looking forward, we plan on moving towards an additional up listing to the OTCQB designation.”

Greyson is preparing a complete shareholder update to be released in the near future that will outline recent corporate developments, provide details about its Oil and Gas investment, as well as schedule a time for a shareholder conference call in early 2013.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; http://greysonintl.com and join the Greyson International's Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contacts

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International, Inc.